Literature DB >> 21286947

Genetics of neurodegeneration with brain iron accumulation.

Allison Gregory1, Susan J Hayflick.   

Abstract

The condition originally called Hallervorden-Spatz syndrome is a collection of related disorders involving abnormal iron accumulation in the basal ganglia, usually manifesting with a movement disorder. To date, mutations in the following genes have been associated with neurodegeneration with brain iron accumulation (NBIA) phenotypes: PANK2, PLA2G6, FA2H, ATP13A2, C2orf37, CP, and FTL. This collection, now classified under the umbrella term NBIA, continues to evolve as new genes and associated phenotypes are recognized. As this body of information continues to grow, better approaches to diagnosis and treatment have become available. Continued investigations of the underlying pathogenesis of disease, with a focus on lipid, iron, and energy metabolism, will lead to the identification of new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286947      PMCID: PMC5908240          DOI: 10.1007/s11910-011-0181-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  50 in total

1.  Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation.

Authors:  David Crosiers; Berten Ceulemans; Bram Meeus; Karen Nuytemans; Philippe Pals; Christine Van Broeckhoven; Patrick Cras; Jessie Theuns
Journal:  Parkinsonism Relat Disord       Date:  2010-11-20       Impact factor: 4.891

2.  Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.

Authors:  Anil Rana; Erwin Seinen; Katarzyna Siudeja; Remco Muntendam; Balaji Srinivasan; Johannes J van der Want; Susan Hayflick; Dirk-Jan Reijngoud; Oliver Kayser; Ody C M Sibon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

4.  Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Michael C Kruer; Coro Paisán-Ruiz; Nathalie Boddaert; Moon Y Yoon; Hiroko Hama; Allison Gregory; Alessandro Malandrini; Randall L Woltjer; Arnold Munnich; Stephanie Gobin; Brenda J Polster; Silvia Palmeri; Simon Edvardson; John Hardy; Henry Houlden; Susan J Hayflick
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

5.  Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1.

Authors:  Abdulaziz Al-Semari; Saeed Bohlega
Journal:  Am J Med Genet A       Date:  2007-01-15       Impact factor: 2.802

6.  Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration.

Authors:  Martin Krause; Wolfgang Fogel; Volker Tronnier; Sabine Pohle; Konstanze Hörtnagel; Ute Thyen; Jens Volkmann
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

7.  Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article.

Authors:  A Leland Albright; Susan S Ferson
Journal:  J Neurosurg Pediatr       Date:  2009-01       Impact factor: 2.375

8.  Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia.

Authors:  Simon Edvardson; Hiroko Hama; Avraham Shaag; John Moshe Gomori; Itai Berger; Dov Soffer; Stanley H Korman; Ilana Taustein; Ann Saada; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2008-11       Impact factor: 11.025

9.  Huntington's disease phenocopies are clinically and genetically heterogeneous.

Authors:  Edward J Wild; Ese E Mudanohwo; Mary G Sweeney; Susanne A Schneider; Jon Beck; Kailash P Bhatia; Martin N Rossor; Mary B Davis; Sarah J Tabrizi
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

10.  Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.

Authors:  Lucio Santoro; Guido J Breedveld; Fiore Manganelli; Rosa Iodice; Chiara Pisciotta; Maria Nolano; Francesca Punzo; Mario Quarantelli; Sabina Pappatà; Alessio Di Fonzo; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2010-09-21       Impact factor: 2.660

View more
  37 in total

1.  As iron goes, so goes disease?

Authors:  Susan J Hayflick; Penelope Hogarth
Journal:  Haematologica       Date:  2011-11       Impact factor: 9.941

2.  Novel compound heterozygous frameshift mutations of C2orf37 in a familial Indian case of Woodhouse-Sakati syndrome.

Authors:  Mansoor C Abdulla; Anas M Alazami; Jemshad Alungal; Jassim M Koya; Mohthash Musambil
Journal:  J Genet       Date:  2015-09       Impact factor: 1.166

3.  Early-onset epileptic encephalopathy as the initial clinical presentation of WDR45 deletion in a male patient.

Authors:  Affef Abidi; Cécile Mignon-Ravix; Pierre Cacciagli; Nadine Girard; Mathieu Milh; Laurent Villard
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

4.  De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood.

Authors:  Hirotomo Saitsu; Taki Nishimura; Kazuhiro Muramatsu; Hirofumi Kodera; Satoko Kumada; Kenji Sugai; Emi Kasai-Yoshida; Noriko Sawaura; Hiroya Nishida; Ai Hoshino; Fukiko Ryujin; Seiichiro Yoshioka; Kiyomi Nishiyama; Yukiko Kondo; Yoshinori Tsurusaki; Mitsuko Nakashima; Noriko Miyake; Hirokazu Arakawa; Mitsuhiro Kato; Noboru Mizushima; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2013-02-24       Impact factor: 38.330

5.  Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.

Authors:  Monika B Hartig; Arcangela Iuso; Tobias Haack; Tomasz Kmiec; Elzbieta Jurkiewicz; Katharina Heim; Sigrun Roeber; Victoria Tarabin; Sabrina Dusi; Malgorzata Krajewska-Walasek; Sergiusz Jozwiak; Maja Hempel; Juliane Winkelmann; Matthias Elstner; Konrad Oexle; Thomas Klopstock; Wolfgang Mueller-Felber; Thomas Gasser; Claudia Trenkwalder; Valeria Tiranti; Hans Kretzschmar; Gerd Schmitz; Tim M Strom; Thomas Meitinger; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

Review 6.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

7.  WDR45 contributes to neurodegeneration through regulation of ER homeostasis and neuronal death.

Authors:  Huida Wan; Qi Wang; Xiuting Chen; Qiufang Zeng; Yanjiao Shao; Houqin Fang; Xun Liao; Hu-Song Li; Ming-Gang Liu; Tian-Le Xu; Miaomiao Diao; Dali Li; Bo Meng; Bin Tang; Zhuohua Zhang; Lujian Liao
Journal:  Autophagy       Date:  2019-06-23       Impact factor: 16.016

8.  Lessons from a pair of siblings with BPAN.

Authors:  Yuri A Zarate; Julie R Jones; Melanie A Jones; Francisca Millan; Jane Juusola; Annette Vertino-Bell; G Bradley Schaefer; Michael C Kruer
Journal:  Eur J Hum Genet       Date:  2015-11-18       Impact factor: 4.246

Review 9.  Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015).

Authors:  Giulio Zuccoli; Michael Paul Yannes; Raffaele Nardone; Ariel Bailey; Amy Goldstein
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

10.  β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.

Authors:  Susan J Hayflick; Michael C Kruer; Allison Gregory; Tobias B Haack; Manju A Kurian; Henry H Houlden; James Anderson; Nathalie Boddaert; Lynn Sanford; Sami I Harik; Vasuki H Dandu; Nardo Nardocci; Giovanna Zorzi; Todd Dunaway; Mark Tarnopolsky; Steven Skinner; Kenton R Holden; Steven Frucht; Era Hanspal; Connie Schrander-Stumpel; Cyril Mignot; Delphine Héron; Dawn E Saunders; Margaret Kaminska; Jean-Pierre Lin; Karine Lascelles; Stephan M Cuno; Esther Meyer; Barbara Garavaglia; Kailash Bhatia; Rajith de Silva; Sarah Crisp; Peter Lunt; Martyn Carey; John Hardy; Thomas Meitinger; Holger Prokisch; Penelope Hogarth
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.